ImStem Biotechnology
Dr. Hongkui Deng is a Professor of Cell Biology and Genetics, College of Life Sciences, Peking University. Mr. Deng had served as a Member of the Scientific Advisory Board at Stemgent, Inc. He is best known for the development of small chemical-induced pluripotent stem cells and the development of stem cells that can produce naturally. He is one of the winners of the Bill & Melinda Gates Foundation's Grand Challenges in Global Health. He won $1.9 million for a proposal to use stem cells to create mouse models for testing HIV and hepatitis C vaccines. Mr. Deng received his Ph.D. in Immunology at the University of California at Los Angeles.
This person is not in the org chart
This person is not in any offices
ImStem Biotechnology
1 followers
Imstem Biotechnology is a biotechnology company focusing on developing cell therapeutic products derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases, and autoimmune diseases.